Lantus 3.64mg / 1ml Injection
PDF Leaflet Revision Date: 30 September 2016
Clinical Summary
Quick overview from the medicine insert
Indication
For treatment of diabetes mellitus in patients requiring insulin.
Dosage (summary)
Subcutaneous injection once daily, at the same time each day.
Onset of Action / Duration
Onset: Slow, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Oral antidiabetic agents
- ACE inhibitors
- Corticosteroids
- Beta-blockers
Contraindications
- Hypersensitivity to LANTUS
- Children < 6 years
Common side effects
- Hypoglycaemia
- Injection site reactions
- Lipohypertrophy
Counselling Points
- Monitor blood glucose regularly.
- Rotate injection sites.
- Be aware of hypoglycaemia symptoms.
Serious warnings
- Risk of severe hypoglycaemia
- Not for diabetic ketoacidosis
Important Disclaimer
The Lantus 3.64mg / 1ml Injection professional information leaflet below is the property of Sanofi-Aventis and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
